Manchester Dysmorphology and Developmental Disorders Conference

20th Manchester Dysmorphology and Developmental Disorders Conference 2025

We are delighted to announce that the abstract submission for the 20^th Manchester Dysmorphology and Developmental Disorders Conference (MDC) 2025, being held Sunday 16^th November – Wednesday 19^th November 2025 at the Hilton Deansgate Manchester, is now open!

For more information on this year’s conference and for further guidance on the submission process, please click here.

Introduction

The Manchester Dysmorphology Conference (MDC) is a biennial event that has brought together global experts in genomic syndromology since 1984. Established by Professor Dian Donnai, MDC promotes the exchange of knowledge and ideas to advance the understanding of developmental disorders and congenital malformations. Each conference offers leading-edge content and a supportive setting, encouraging discussions, building collaborations, and inspiring innovative strategies to improve the lives of individuals living with rare conditions.

Purpose

Cutting-Edge Content: Stay at the forefront of research in developmental disorders, congenital malformations, and rare conditions.
Global Collaboration: Network with an international community of clinicians, geneticists, researchers, and healthcare professionals.
Patient-Centered Impact: Translate new discoveries into real-world applications that enhance patient well-being and support.
Welcoming Environment: Experience an atmosphere designed to encourage conversation, collaboration, and the sharing of transformative ideas

Past Conferences and Archives

Below is a curated look at the history of the Manchester Dysmorphology Conference, featuring the full programmes of each previous event:

Highlights from the 2023 Manchester Dysmorphology Conference (MDC19)

Held from October 16–18, 2023 at the Hilton Deansgate in Manchester, MDC19 convened 252 international genomics experts representing 50 countries. Across three days:
83 Presentations: Delivered cutting-edge research on the science, diagnosis, and treatment of rare conditions.
Collaborative Spirit: Fostered a friendly, open setting that promoted deep discussions, forged new collaborations, and inspired innovative solutions for patient care.
Global Impact: Highlighted the significance of worldwide cooperation in advancing genomics and dysmorphology research.